Matchmaker, Matchmaker

Free virtual event helps healthtech companies go global

Great collaboration doesn't abide by borders. Photo by Blue Images/Getty

In the growing healthtech sector, two is better than one — two partners, that is. If you've ever been curious what collaborating with an international company would be like, HealthTech Beyond Borders can provide answers.

The free virtual event, sponsored by ProChile and set for August 10-13, 2021, was created to offer matchmaking opportunities and set the scene for global collaborations focused on innovative medical technology between companies from Chile and the United States.

A curated group of successful Chilean and U.S. healthtech companies are participating, including those that specialize in artificial intelligence, 3-D printing, medical robotics, gene therapies, nanomedicine, neurotechnology, eye care tech, telehealth, imaging diagnostics, wellness and fitness, mental health, and more.

You can explore everything from software solutions and medical facility management to healthcare products and services, and even venture capital opportunities.

And if you're wondering "why Chile?" there are some pretty compelling stats.

A whopping 13 percent of Chile's startups are healthcare related (according to the Science, Technology, Knowledge, and Innovation Ministry of Chile) and the growth rate of robotic surgeries done in Chile between 2010 and 2018 increased by 674 percent.

An estimated 93.7 percent of the Chilean population is covered by health insurance, and the county has one of the highest shares of health spending in relation to its gross domestic product (GDP) in Latin America.

Likewise, the United States is the top destination for Chilean exports of medical devices, representing over 25 percent of the total Chilean exports in the sector.

The Free Trade Agreement of 2004 and the Duty-Free status between the two countries also make Chile an attractive and reliable trade partner. So much so, that the U.S. is the No. 1 investor in Chile, with $22 billion invested in projects in the last 7 years.

And with Houston being home to the largest hospital center in the world — Texas Medical Center, which served 13 million patients in 2020 — it only makes sense that healthtech companies here would be looking for ways to improve and expand. Reserve your free spot for the event here.

Trending News

Building Houston

 
 

Houston-based medical device and biotech startup Steradian Technologies has been recognized by the Bill and Melinda Gates Foundation. Photo by Dwight C. Andrews/Greater Houston Convention and Visitors Bureau

A female-founded biotech startup has announced that it has received a grant from the Bill & Melinda Gates Foundation.

Steradian Technologies has developed a breath-based collection device that can be used with diagnostic testing systems. Called RUMI, the device is non-invasive and fully portable and, according to a news release, costs the price of a latte.

“We are extremely honored to receive this award and be recognized by the Bill & Melinda Gates Foundation, a leader in global health. This funding will propel our work in creating deep-tech diagnostics and products to close the equity gap in global public health," says Asma Mirza, CEO and co-founder of Steradian Technologies, in the release. “The RUMI will demonstrate that advanced technology can be delivered to all areas of the world, ensuring the Global South and economically exploited regions receive access to high-fidelity diagnostics instead of solutions that are ill-suited to the environment.”

RUMI uses novel photon-based detection to collect and diagnose infectious diseases in breath within 30-seconds, per the release, and will be the first human bio-aerosol specimen collector to convert breath into a fully sterile liquid sample and can be used for many applications in direct disease detection.

"As the healthcare industry continues to pursue less invasive diagnostics, we are very excited that the foundation has identified our approach to breath-based sample collection as a standout worthy of their support," says John Marino, chief of product development and co-founder. “We look forward to working with them to achieve our goals of better, faster, and safer diagnostics."

Founded in 2017, Steradian Technologies is funded and supported by XPRIZE, Johnson & Johnson’s Lung Cancer Initiative, JLABS TMCi, Capital Factory, Duke Institute of Global Health, and Johnson & Johnson’s Center for Device Innovation.

The amount granted by the Bill & Melinda Gates Foundation was not disclosed. The Seattle-based foundation is led by CEO Mark Suzman and co-chaired by Bill Gates and Melinda French Gatess.

Trending News